How is the Galmed Pharmaceuticals Ltd today?

The Galmed Pharmaceuticals Ltd today is trading in the down by 0.00% at 1.43.

How has Galmed Pharmaceuticals Ltd performed historically?

The Galmed Pharmaceuticals Ltd is currently trading down 0.00% on an intraday basis in the past week the index rose 2.88%. The index has been down -33.18% in the past quarter and fell -67.79% in the past year. You can view this in the overview section.

What is Galmed Pharmaceuticals Ltd Annual Net Profit?

Galmed Pharmaceuticals Ltd Annual Net Profit fell 8.75% in the last year to $7.52 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Galmed Pharmaceuticals Ltd Price to Earning Ratio?

Galmed Pharmaceuticals Ltd Price to Earning Ratio is -0.44, which is negative.

What is Galmed Pharmaceuticals Ltd Stock Price?

Galmed Pharmaceuticals Ltd Stock Price fell 67.79% and underperformed its sector by 123.26% in the past year.

What is Galmed Pharmaceuticals Ltd Quarterly Net profit?

Galmed Pharmaceuticals Ltd Quarterly Net profit rose 13.41% YoY to $1.1 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Galmed Pharmaceuticals Ltd Debt to Equity Ratio?

Galmed Pharmaceuticals Ltd Debt to Equity Ratio is zero as the company is debt-free.

What is Galmed Pharmaceuticals Ltd Return on Equity(ROE)?

Galmed Pharmaceuticals Ltd Return on Equity(ROE) for the last financial year was -49.77%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Galmed Pharmaceuticals Ltd Mutual Fund Holding?

Galmed Pharmaceuticals Ltd Mutual Fund Holding decreased by 0.03% in the last quarter to 0.08.

What is Galmed Pharmaceuticals Ltd Institutional Holding?

Galmed Pharmaceuticals Ltd Institutional Holding increased by 0.26% in the last quarter to 2.48.

Galmed Pharmaceuticals Ltd XNAS: GLMD

Galmed Pharmaceuticals Ltd Live Share Price Today, Share Analysis and Chart

Name: Galmed Pharmaceuticals Ltd: Is Infosys Ltd. worth buying?
Item: Galmed Pharmaceuticals Ltd
Rating: 1.05716675
Author: Trendlyne DVM scores

about

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PS...

1.43 0.00 (0.00%)

89.47% Fall from 52W High

179.3K XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Galmed Pharmaceuticals Ltd is on 10 Jun 2025 for the purpose of Galmed Pharmaceuticals Ltd Annual General Meeting for 2024 See details

Not Eligible

Expensive Valuation

16.2 / 100

Technically Bearish

26.1 / 100

No estimates available

Galmed Pharmaceuticals Ltd Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Galmed Pharmaceuticals Ltd Live Share Price Today, Share Analysis and Chart

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PS...

89.47% Fall from 52W High

SWOT Analysis

Galmed Pharmaceuticals Ltd Live Price Chart

Galmed Pharmaceuticals Ltd FAQ

How is Galmed Pharmaceuticals Ltd today?

Galmed Pharmaceuticals Ltd today is trading in the red, and is down by 0.00% at 1.43.

How has Galmed Pharmaceuticals Ltd performed historically?

Galmed Pharmaceuticals Ltd is currently trading down 0.00% on an intraday basis. In the past week the stock rose 2.88%. stock has been down -33.18% in the past quarter and fell -67.79% in the past year. You can view this in the overview section.